Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization
Jorge González-Zamora1, María Hernandez2, Sergio Recalde2
1Retinal Pathologies and New Therapies Group, Experimental Ophthalmology Laboratory, Department of Ophthalmology, Clinica Universidad de Navarra, 31008 Pamplona, Spain.
Abstract:
Age-related macular degeneration (AMD) is a leading cause of severe vision loss in older individuals in developed countries. Despite advances in our understanding of AMD, its pathophysiology remains poorly understood. Matrix metalloproteinases (MMPs) have been proposed to play a role in AMD development. In this study, we aimed to characterize MMP-13 in AMD. We used retinal pigment epithelial cells, a murine model of laser-induced choroidal neovascularization, and plasma samples from patients with neovascular AMD to conduct our study. Our results show that MMP13 expression significantly increased under oxidative stress conditions in cultured retinal pigment epithelial cells. In the murine model, MMP13 was overexpressed in both retinal pigment epithelial cells and endothelial cells during choroidal neovascularization. Additionally, the total MMP13 levels in the plasma of patients with neovascular AMD were significantly lower than those in the control group. This suggests a reduced diffusion from the tissues or release from circulating cells in the bloodstream, given that the number and function of monocytes have been reported to be deficient in patients with AMD. Although more studies are needed to elucidate the role of MMP13 in AMD, it could be a promising therapeutic target for treating AMD.
Insights
Matrix metalloproteinase-13 (MMP13) is implicated in age-related macular degeneration (AMD). MMP13 expression increased in AMD models, but plasma levels were lower in patients, suggesting complex roles in this vision-impairing disease.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- Age-related macular degeneration (AMD) is a primary cause of vision loss in developed nations.
- The underlying pathophysiology of AMD is not fully understood.
- Matrix metalloproteinases (MMPs) are potential contributors to AMD development.
Purpose of the Study:
- To characterize the role and expression of MMP-13 in age-related macular degeneration.
- Investigate MMP-13 in retinal pigment epithelial cells, a murine model, and patient plasma.
Main Methods:
- Utilized cultured retinal pigment epithelial cells subjected to oxidative stress.
- Employed a murine model of laser-induced choroidal neovascularization.
- Analyzed plasma samples from patients with neovascular AMD and healthy controls.
Main Results:
- MMP13 expression significantly increased in retinal pigment epithelial cells under oxidative stress.
- MMP13 was overexpressed in retinal pigment epithelial and endothelial cells during choroidal neovascularization in mice.
- Plasma MMP13 levels were significantly lower in patients with neovascular AMD compared to controls.
Conclusions:
- MMP13 expression is altered in AMD, increasing under stress and during neovascularization.
- Lower plasma MMP13 levels in AMD patients may indicate reduced diffusion or release from compromised monocytes.
- MMP-13 presents a potential therapeutic target for age-related macular degeneration.
More Related Videos
09:37A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
Published on: July 14, 2016
10:14Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
Published on: May 26, 2023
